Xanthine Oxidase Inhibition in Renal Transplant Recipients

Summary

Cardiovascular disease is the leading cause of mortality in kidney transplantation. The enzyme xanthine oxidase may play an important role in the cardiovascular disease of kidney transplant recipients. Inhibiting this enzyme with allopurinol may improve vascular health and protects against cardiovascular complications.

Timeline

Start

2011-02

Primary completion

2018-08-10

Completion

2018-08-10

Outcome

Outcome not reported

Stopped (Business): “Study was not funded”

Drugs

Indications